Precision Biosciences (DTIL) Liabilities and Shareholders Equity (2018 - 2026)
Precision Biosciences (DTIL) posted Liabilities and Shareholders Equity of $125.92 million for fiscal Q2 2026 (quarter ended Jun 30, 2026), up 15.6% from $108.93 million a year earlier but down 12.5% from the prior quarter.
Powered by 
Analysis
Precision Biosciences (DTIL) Liabilities and Shareholders Equity (2018 - 2026) Analysis & Trends
At the end of FY2025 (ended Dec 31, 2025), Precision Biosciences' Liabilities and Shareholders Equity came in at $154.42 million, up 13.2% from FY2024.
- Annual Liabilities and Shareholders Equity shows a five-year compound annual growth rate of 0.6% (FY2020 to FY2025).
- In prior fiscal years, Precision Biosciences' Liabilities and Shareholders Equity was $136.39 million in FY2024 (-14.6%), $159.78 million in FY2023 (-32.9%), $238.17 million in FY2022 (+12.6%) and $211.5 million in FY2021 (+40.9%).
- Quarterly Liabilities and Shareholders Equity has run from a low of $93.51 million in fiscal Q3 2025 to a high of $297.16 million in fiscal Q2 2022 over five years.
- On a year-over-year basis, Liabilities and Shareholders Equity has increased in each of the last three quarters, with an average decline of 10.4% over the last eight quarters.
- The strongest year-over-year quarter for Liabilities and Shareholders Equity in the past five years was fiscal Q4 2021, with growth of 40.9%; the weakest was fiscal Q3 2023, with a decline of 39.5%.
- According to Business Quant data, Liabilities and Shareholders Equity for the three prior fiscal quarters was $143.89 million (Q1 2026), $154.42 million (Q4 2025) and $93.51 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Liabilities and Shareholders Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | 201.06 Bn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | 135.12 Bn |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | 129.80 Bn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | 122.03 Bn |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | 115.83 Bn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | 95.64 Bn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | 49.36 Bn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | 201.13 Bn |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | 27.42 Bn |
| 10 | Precision Biosciences | 165.47 Mn | -183.71 Mn | - | 125.92 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 125.92 Mn |
| Mar 31, 2026 | 143.89 Mn |
| Dec 31, 2025 | 154.42 Mn |
| Sep 30, 2025 | 93.51 Mn |
| Jun 30, 2025 | 108.93 Mn |
| Mar 31, 2025 | 124.41 Mn |
| Dec 31, 2024 | 136.39 Mn |
| Sep 30, 2024 | 153.26 Mn |
| Jun 30, 2024 | 165.80 Mn |
| Mar 31, 2024 | 184.74 Mn |
| Dec 31, 2023 | 159.78 Mn |
| Sep 30, 2023 | 164.34 Mn |
| Jun 30, 2023 | 181.70 Mn |
| Mar 31, 2023 | 204.50 Mn |
| Dec 31, 2022 | 238.17 Mn |
| Sep 30, 2022 | 271.73 Mn |
| Jun 30, 2022 | 297.16 Mn |
| Mar 31, 2022 | 181.35 Mn |
| Dec 31, 2021 | 211.50 Mn |
| Sep 30, 2021 | 227.20 Mn |
API Access
Precision Biosciences Liabilities and Shareholders Equity API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=liabilities-and-shareholders-equity&ticker=DTIL&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "liabilities-and-shareholders-equity", "ticker": "DTIL", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=liabilities-and-shareholders-equity&ticker=DTIL&period=max&api_key=YOUR_API_KEY");
const data = await res.json();